论文部分内容阅读
美国权威学术期刊《美国医学会杂志》的一篇文章让美国FDA即将出台的一项似乎对企业是绝对利好的政策变得悬而未决。这段时间,对于美国的制药企业来说,可能真的是有些灰色的日子。4月17日,美国权威学术期刊《美国医学会杂志》(《JAMA》)突然爆出冷门消息,已经沉寂一时
An article by the American authoritative academic journal The Journal of the American Medical Association has left the FDA a pending policy that appears to be absolutely favorable to the business. This time, for the United States pharmaceutical companies, may be really some gray days. April 17, the authoritative academic journal “JAMA” suddenly broke the news, has been quiet